We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of MURA yet.

MURA Hedge Fund Activity: Q4 2025 in Review

0 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2025, worth a combined $0 — down 100% from $11M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of MURA and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was OrbiMed, exiting entirely with an estimated $1.22M sold.

  • 0 institutional investors held Mural Oncology (MURA) as of Q4 2025, down from 61 in Q3 2025.
  • Funds reported $0 of Mural Oncology stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Mural Oncology positions in Q4 2025 and 61 closed out, a net change of -61 holders.
  • The largest Mural Oncology seller in Q4 2025 was OrbiMed, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2025.